Novelis Pharmaceuticals Private Limited
About Novelis Pharmaceuticals Private Limited
Data last updated:
Novelis Pharmaceuticals Private Limited is a private limited company based in Kota, Rajasthan, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24100RJ2020PTC069258.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anirudh Gautam and Chandramani Gautam.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 11 – A – 26 Mahaveer Nagar Iiird Parijaat Scheme, Kota, Rajasthan, India – 324005.
Company details
Contact details
Novelis Pharmaceuticals Private Limited's registered office is in Kota, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address11 – A – 26 Mahaveer Nagar Iiird Parijaat Scheme, Kota, Rajasthan, India – 324005
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Novelis Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Novelis Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Novelis Pharmaceuticals Private Limited, buy the company report.
Financials of Novelis Pharmaceuticals Private Limited
FY 2025 filings availableNovelis Pharmaceuticals Private Limited reported revenue of ₹5,000 for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Novelis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Novelis Pharmaceuticals Private Limited
Novelis Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anirudh Gautam Also directs: Juniper Stones and Minerals Private Limited | Director | 26 Jun 2020 | 6 Years 4 Months | Current |
| Chandramani Gautam | Director | 26 Jun 2020 | 6 Years 4 Months | Current |
Auditor
Novelis Pharmaceuticals Private Limited is audited by BHUTORIA GANESAN & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BHUTORIA GANESAN & CO | FY 2021 | 004465C |
Shareholding
The shareholding of Novelis Pharmaceuticals Private Limited is on record for FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Novelis Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Novelis Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Novelis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Novelis Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 29, 2024.
GST
No GST registration is on our record for Novelis Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Novelis Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Anirudh Gautam was appointed as Director on 26 Jun 2020.
Frequently asked questions
Novelis Pharmaceuticals is an active private limited company based in Kota, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 June 2020 (6+ years old) and is registered under CIN U24100RJ2020PTC069258.
Novelis Pharmaceuticals has 2 current directors:
- Anirudh Gautam - Director
- Chandramani Gautam - Director
The latest financial statements of Novelis Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Novelis Pharmaceuticals is U24100RJ2020PTC069258. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Novelis Pharmaceuticals was incorporated on 26 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Jaipur.
Anirudh Gautam was appointed as Director on 26 Jun 2020. Chandramani Gautam was appointed as Director on 26 Jun 2020.
The registered office of Novelis Pharmaceuticals is at 11 – A – 26 Mahaveer Nagar Iiird Parijaat Scheme, Kota, Rajasthan, India – 324005.
Novelis Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Novelis Pharmaceuticals can be reached at its registered office: 11 – A – 26 Mahaveer Nagar Iiird Parijaat Scheme, Kota, Rajasthan, India – 324005.
Novelis Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Jaipur.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
